Trophectoderm biopsy protocols may impact the rate of mosaic blastocysts in cycles with pre-implantation genetic testing for aneuploidy.


Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
May 2021
Historique:
received: 21 12 2020
accepted: 25 02 2021
pubmed: 5 3 2021
medline: 9 9 2021
entrez: 4 3 2021
Statut: ppublish

Résumé

This study aimed to analyze the impact of different biopsy protocols on the rate of mosaic blastocysts. This is a retrospective cohort study which included 115 cycles with pre-implantation genetic testing for aneuploidy (PGT-A). Two groups were allocated based on the biopsy protocols: method 1 group, the zona pellucida (ZP) was drilled on day 3 embryos followed by trophectoderm (TE) biopsy; and method 2 group, the ZP was opened on day 5 or 6 blastocysts followed by TE biopsy. All biopsy samples were assessed using next-generation sequencing (NGS) at a single reference laboratory. The euploid, aneuploid, and mosaic blastocyst rates and clinical outcomes were compared. The mosaicism rate in the method 1 group was 19.58%, significantly higher than the method 2 group (8.12%; P < 0.05). No statistically significant difference was observed in euploid, aneuploid blastocyst rates, and clinical pregnancy rates between the two groups. Logistic regression analysis indicated that the biopsy protocols were independently associated with the mosaicism rates among all the variables. The present study showed that different biopsy protocols may have an impact on the mosaic blastocyst rate. ZP opening on day 3 combined with TE biopsy might increase the incidence of mosaic blastocysts.

Identifiants

pubmed: 33660205
doi: 10.1007/s10815-021-02137-w
pii: 10.1007/s10815-021-02137-w
pmc: PMC7929899
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1153-1162

Subventions

Organisme : Chongqing Municipal Public Health Bureau, Chongqing People's Municipal Government
ID : 2019MSXM067
Organisme : Chongqing Municipal Public Health Bureau, Chongqing People's Municipal Government
ID : 2020MSXM086

Références

Gleicher N, Orvieto R. Is the hypothesis of preimplantation genetic screening (PGS) still supportable? A review. J Ovarian Res. 2017;10:21.
doi: 10.1186/s13048-017-0318-3
Morin SJ, Kaser DJ, Franasiak JM. The dilemma of aneuploidy screening on low responders. Curr Opin Obstet Gynecol. 2018;30:179–84.
doi: 10.1097/GCO.0000000000000449
Sullivan-Pyke C, Dokras A. Preimplantation genetic screening and preimplantation genetic diagnosis. Obstet Gynecol Clin N Am. 2018;45:113–25.
doi: 10.1016/j.ogc.2017.10.009
Murphy LA, Seidler EA, Vaughan DA, Resetkova N, Penzias AS, Toth TL, et al. To test or not to test? A framework for counselling patients on preimplantation genetic testing for aneuploidy (PGT-A). Hum Reprod. 2019;34:268–75.
doi: 10.1093/humrep/dey346
Somigliana E, Busnelli A, Paffoni A, Capalbo A, Vigano P, Riccaboni A, et al. Cost-effectiveness of preimplantation genetic testing for aneuploidies. Fertil Steril. 2019;111:1169–76.
doi: 10.1016/j.fertnstert.2019.01.025
Greco E, Minasi MG, Fiorentino F. Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. N Engl J Med. 2015;373:2089–90.
doi: 10.1056/NEJMc1500421
Popovic M, Dheedene A, Christodoulou C, Taelman J, Dhaenens L, Van Nieuwerburgh F, et al. Chromosomal mosaicism in human blastocysts: the ultimate challenge of preimplantation genetic testing? Hum Reprod. 2018;33:1342–54.
doi: 10.1093/humrep/dey106
Munne S, Blazek J, Large M, Martinez-Ortiz PA, Nisson H, Liu E, et al. Detailed investigation into the cytogenetic constitution and pregnancy outcome of replacing mosaic blastocysts detected with the use of high-resolution next-generation sequencing. Fertil Steril. 2017;108:62–71 e68.
doi: 10.1016/j.fertnstert.2017.05.002
Sachdev NM, Maxwell SM, Besser AG, Grifo JA. Diagnosis and clinical management of embryonic mosaicism. Fertil Steril. 2017;107:6–11.
doi: 10.1016/j.fertnstert.2016.10.006
Capalbo A, Ubaldi FM, Rienzi L, Scott R, Treff N. Detecting mosaicism in trophectoderm biopsies: current challenges and future possibilities. Hum Reprod. 2017;32:492–8.
pubmed: 27738115
Spinella F, Fiorentino F, Biricik A, Bono S, Ruberti A, Cotroneo E, et al. Extent of chromosomal mosaicism influences the clinical outcome of in vitro fertilization treatments. Fertil Steril. 2018;109:77–83.
doi: 10.1016/j.fertnstert.2017.09.025
Liu YL, Yu TN, Chen CH, Wang PH, Chen CH, Tzeng CR. Healthy live births after mosaic blastocyst transfers with the use of next-generation sequencing. Taiwan J Obstet Gynecol. 2019;58:872–6.
doi: 10.1016/j.tjog.2019.07.032
Homer HA. Preimplantation genetic testing for aneuploidy (PGT-A): the biology, the technology and the clinical outcomes. Aust N Z J Obstet Gynaecol. 2019;59:317–24.
doi: 10.1111/ajo.12960
Lin PY, Lee CI, Cheng EH, Huang CC, Lee TH, Shih HH, et al. Clinical outcomes of single mosaic embryo transfer: high-level or low-level mosaic embryo, does it matter? J Clin Med. 2020;9:1695.
doi: 10.3390/jcm9061695
Kahraman S, Cetinkaya M, Yuksel B, Yesil M, Pirkevi CC. The birth of a baby with mosaicism resulting from a known mosaic embryo transfer: a case report. Hum Reprod. 2020;35:727–33.
doi: 10.1093/humrep/dez309
Munne S, Weier HU, Grifo J, Cohen J. Chromosome mosaicism in human embryos. Biol Reprod. 1994;51:373–9.
doi: 10.1095/biolreprod51.3.373
Taylor TH, Gitlin SA, Patrick JL, Crain JL, Wilson JM, Griffin DK. The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans. Hum Reprod Update. 2014;20:571–81.
doi: 10.1093/humupd/dmu016
Zhao H, Tao W, Li M, Liu H, Wu K, Ma S. Comparison of two protocols of blastocyst biopsy submitted to preimplantation genetic testing for aneuploidies: a randomized controlled trial. Arch Gynecol Obstet. 2019;299:1487–93.
doi: 10.1007/s00404-019-05084-1
Kim TG, Neblett MF, Shandley LM, Omurtag K, Hipp HS, Kawwass JF. National mosaic embryo transfer practices: a survey. Am J Obstet Gynecol. 2018;219:602.e1–7.
doi: 10.1016/j.ajog.2018.09.030
Bean CJ, Hassold TJ, Judis L, Hunt PA. Fertilization in vitro increases non-disjunction during early cleavage divisions in a mouse model system. Hum Reprod. 2002;17:2362–7.
doi: 10.1093/humrep/17.9.2362
Palmerola KL, Vitez SF, Amrane S, Fischer CP, Forman EJ. Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A). J Assist Reprod Genet. 2019;36:153–7.
doi: 10.1007/s10815-018-1347-6
Palermo G, Munne S, Cohen J. The human zygote inherits its mitotic potential from the male gamete. Hum Reprod. 1994;9:1220–5.
doi: 10.1093/oxfordjournals.humrep.a138682
Tarozzi N, Nadalini M, Lagalla C, Coticchio G, Zaca C, Borini A. Male factor infertility impacts the rate of mosaic blastocysts in cycles of preimplantation genetic testing for aneuploidy. J Assist Reprod Genet. 2019;36:2047–55.
doi: 10.1007/s10815-019-01584-w
Munne S, Magli C, Adler A, Wright G, de Boer K, Mortimer D, et al. Treatment-related chromosome abnormalities in human embryos. Hum Reprod. 1997;12:780–4.
doi: 10.1093/humrep/12.4.780
Cascales A, Lledó B, Ortiz JA, Morales R, Ten J, Llácer J, et al. Effect of ovarian stimulation on embryo aneuploidy and mosaicism rate. Syst Biol Reprod Med. 2021;07:1–8.
Fragouli E, Munné WD. The cytogenetic constitution of human blastocysts: insights from comprehensive chromosome screening strategies. Hum Reprod Update. 2019;25:15–33.
doi: 10.1093/humupd/dmy036
Hernandez-Nieto C, Lee JA, Slifkin R, Sandler B, Copperman AB, Flisser E. What is the reproductive potential of day 7 euploid embryos? Hum Reprod. 2019;34:1697–706.
doi: 10.1093/humrep/dez129
McArthur SJ, Leigh D, Marshall JT, de Boer KA, Jansen RP. Pregnancies and live births after trophectoderm biopsy and preimplantation genetic testing of human blastocysts. Fertil Steril. 2005;84:1628–36.
doi: 10.1016/j.fertnstert.2005.05.063
Yang D, Feng D, Gao Y, Sagnelli M, Wang X, Li D. An effective method for trophectoderm biopsy using mechanical blunt dissection: a step-by-step demonstration. Fertil Steril. 2020;114:438–9.
doi: 10.1016/j.fertnstert.2020.05.035
Rubino P, Tapia L. Ruiz de Assin Alonso R, Mazmanian K, Guan L, Dearden L, et al: Trophectoderm biopsy protocols can affect clinical outcomes: time to focus on the blastocyst biopsy technique. Fertil Steril. 2020;113:981–9.
doi: 10.1016/j.fertnstert.2019.12.034
Capalbo A, Rienzi L, Cimadomo D, Maggiulli R, Elliott TA, Wright G, et al. Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts. Hum Reprod. 2014;29:1173–81.
doi: 10.1093/humrep/deu033
Herrero Grassa L, Aparicio Gonzalez M, Cascales Romero L, Ortiz JA, Castillo JC, Garcia-Ajofrin C, et al. Is mosaicism and its characteristics influenced by the method of trophectoderm-biopsy technique employed in PGT-A cycles? Genetic and reproductive outcomes after pulling versus flicking. Abstracts 36th virtual annual meeting of European Society of Human Reproduction and Embryology (ESHRE). 2020; P-246.
Preimplantation Genetic Diagnosis International Society (PGDIS). Guidelines for good practice in PGD: programme requirements and laboratory quality assurance. Reprod Biomed Online.2008;16:134-47.
Xiong S, Han W, Liu JX, Zhang XD, Liu WW, Liu H, et al. Effects of cumulus cells removal after 6 h co-incubation of gametes on the outcomes of human IVF. J Assist Reprod Genet. 2011;28:1205–11.
doi: 10.1007/s10815-011-9630-9
Gardner DK, Lane M. Culture and selection of viable blastocysts: a feasible proposition for human IVF? Hum Reprod Update. 1997;3:367–82.
doi: 10.1093/humupd/3.4.367
Xiong S, Liu JX, Gao Y, Liu WW, Wu LH, Han W, et al. Shortened equilibration time can compromise clinical outcomes in human embryo vitrification. Hum Fertil (Camb). 2016;19:114–9.
doi: 10.1080/14647273.2016.1186848
Capalbo A, Poli M, Cimadomo D, Benini F, Patassini C, Rubio C, et al. Low-degree mosaicism profiles do not provide clinically useful predictive values: interim results from the first multicenter prospective non-selection study on the transfer of mosaic embryos. Eshre Poster Award. 2020;P-502.

Auteurs

Shun Xiong (S)

Chongqing Health Center for Women and Children, Chongqing, People's Republic of China.

Weiwei Liu (W)

Chongqing Health Center for Women and Children, Chongqing, People's Republic of China.

Jiang Wang (J)

Chongqing Health Center for Women and Children, Chongqing, People's Republic of China.

Junxia Liu (J)

Chongqing Health Center for Women and Children, Chongqing, People's Republic of China.

Yang Gao (Y)

Chongqing Health Center for Women and Children, Chongqing, People's Republic of China.

Lihong Wu (L)

Chongqing Health Center for Women and Children, Chongqing, People's Republic of China.

Jiahong Zhu (J)

Chongqing Health Center for Women and Children, Chongqing, People's Republic of China.

Xiangwei Hao (X)

Chongqing Clinical Research Center for Reproductive Medicine, Chongqing, People's Republic of China.

Jingyu Li (J)

Chongqing Key Laboratory of Human Embryo Engineering, Chongqing, People's Republic of China.

Dongyun Liu (D)

Chongqing Health Center for Women and Children, Chongqing, People's Republic of China.

Wei Han (W)

Chongqing Health Center for Women and Children, Chongqing, People's Republic of China. hw2012ivf@sina.com.

Guoning Huang (G)

Chongqing Health Center for Women and Children, Chongqing, People's Republic of China. gnhuang217@sina.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH